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INTRODUCTION
- Operative treatment of prosthetic joint infection (PJI) 
has increased risk for the need of allogenic blood 
transfusion (ABT)
- ABT is associated with higher rates of morbidity and 
death in revision total joint arthroplasty (TJA), 
particularly in the treatment of PJI
- It is unknown how ABT rates differ among the various 
surgical treatments of PJI
- The purpose of this study was to identify the difference 
in ABT requirements between these procedures in the 
setting of a multimodal blood management protocol
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CONCLUSION 
- In a TJA practice that utilizes a multimodal blood 
conservation protocol, ABT rates were high during 
surgical treatment of PJI
- Explantation procedures had high rates of multiple unit 
transfusions, and crossmatching additional units should 
be considered
- Before Re-implantation and when possible for 
explantation, anemia should be addressed
- Further refinement of blood management strategies in 
PJI is necessary
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RESULTS & DISCUSSION
METHOD
- Retrospective review of 165 operative cases of hip and
knee PJI involving 102 patients at a single institution
between 2016 and 2018
- Procedures were categorized as:
1. Irrigation and debridement (I&D) with modular
component exchange (“modular component exchange”)
2. Explantatioin , I&D,with placement of antibiotic spacer
("explantation")
3. Antibiotic spacer exchange with I&D("spacer exchange")
4. Antibiotic spacer removal and prosthetic reimplantation
("reimplantation")
- Procedure types were assessed for differences in ABT rates, 
as well as rates of ABT involving multiple units transfused
- Factors associated with ABT were assessed with a
multilevel mixed-effects regression model
- 77 (54%) of the 143 eligible cases received ABT
- The highest rates of ABT occurred during 
explantations (74%) and spacer exchanges (72%), 
followed by reimplantations (36%) and modular 
component exchanges (33%)
- Lower preoperative hemoglobin level was associated 
with higher odds of ABT (OR 1.9, 1.5-2.5 CI)
- Compared with modular component exchanges, 
explantations, reimplantations, and spacer exchanges 
were associated with greater odds of ABT (Table 1)
- Explantations, reimplantations, and chronic kidney 
disease were associated with greater odds of multiple 
unit transfusions
Table 1: Odds of ABT in 143 cases of operative treatment of PJI
*Referent is I&D with modular component exchange
†Per 1 g/dL decrease in preoperative hemoglobin level
Variable​ Odds Ratio (95% CI)​ P-value​
Explant* 14 (4.0 - 50)​ <0.001
Reimplant* 4.3 (1.1 - 16) 0.031​
Antibiotic spacer exchange* 5.6 (1.1 - 28) 0.037
Current tobacco use 9.0 (1.4 - 58) 0.021​
Chronic kidney disease 6.8 (1.6 - 29) 0.009
Preoperative hemoglobin level† 1.9 (1.5 - 2.5) <0.001
Knee revision vs. Hip revision 0.48 (0.20 - 1.2) 0.112​
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